Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
This is a defining moment for my leadership and the company. The pressure from the board to "wait for more data" is a trap that has destroyed pharmaceutical companies in the past (e.g., Merck with Vioxx). Hiding a safety signal to manipulate stock price is securities fraud and criminal negligence.Read the full answer
As CEO, my overriding duty is to balance patient safety, legal/regulatory compliance, fiduciary responsibility, and long-term corporate survival. A 1-in-8,000 risk of liver failure is rare but severe, potentially fatal, and materially unexpected relative to the current label.Read the full answer